Liver sarcoma

Summary

Liver sarcoma (MONDO:0002397) is a cancer (an umbrella term covering 7 Mondo subtypes) and 1 clinical trial. A subtype of liver cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Umbrella term: 7 Mondo subtypes
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	liver sarcoma
Mondo ID	MONDO:0002397
DOID	DOID:270
NCIT	C4437
SNOMED CT	254601002
UMLS	C0345906
MedGen	87522
GARD	0023130
Anatomy (UBERON)	UBERON:0002107
Is cancer (heuristic)	yes

Also known as: hepatic sarcoma · liver sarcoma · sarcoma of liver · sarcoma of the liver

Disease family

This is a subtype of liver cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system cancer › liver cancer › liver sarcoma

Related subtypes (4): biliary tract cancer, liver lymphoma, calcifying nested epithelial stromal tumor of the liver, carcinoma of liver and intrahepatic biliary tract

Subtypes (7): liver angiosarcoma, liver rhabdomyosarcoma, bile duct sarcoma, liver leiomyosarcoma, liver extraskeletal osteosarcoma, liver fibrosarcoma, undifferentiated (embryonal) sarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT05640960	Not specified	COMPLETED	Undifferentiated Embryonal Sarcoma of the Liver: Evaluation of the Relapse Profile According to the Therapies Administered